New Restrictions on the Use of Benzophenone-3 and Octocrylene as UV Filters in Cosmetic Products
Ingredients: BENZOPHENONE-3 and OCTOCRYLENE

Date of publication: 07/07/2022

Date of application: 27/07/2022

On July 7th, the European Commission published the Regulation (EU) 2022/1176, amending the EU Cosmetics Regulation as regards the use of certain UV filter in cosmetic products. The use of Octocrylene and Benzophenone-3 will be restricted, following the opinions published by the SCCS.
Picture of Liliana Teles

Liliana Teles

Regulatory Affairs Manager
Linkedin Instagram Facebook Address-card

BENZOPHENONE-3 AND OCTOCRYLENE

Benzophenone-3 (CAS number 131-57-7) and Octocrylene (CAS number 6197-30-4) are commonly used UV filters in cosmetics products. They are both included in Annex VI (list of UV filters allowed in cosmetic products) of the European Cosmetics Regulation (No. 1223/2009).

In early 2019, a priority list of 28 potential endocrine disruptors (not already covered by the bans of cosmetic regulation) was established by the European Commission. From these 28 substances, 14 were considered as higher priority (Group A) and the other 14 were included in the low priority group (Group B). The public call for data for the considered higher priority substances was carried out in 2019. (see previous post)

Stakeholders submitted scientific evidence to demonstrate the safety of Benzophenone-3 and Octocrylene as UV filters in cosmetic products and the European Commission asked the Scientific Committee for Consumer Safety (SCCS) to carry out a safety assessment of these ingredients, considering the information provided.

In March 2021 the SCCS published its opinions on Benzophenone-3 (see previous post) and Octocrylene (see previous post).

COMMISSION REGULATION (EU) 2022/1176

On July 7, 2022, the European Commission published the Commission Regulation (EU) 2022/1176, amending Regulation (EC) No 1223/2009 as regards the use of certain UV filter in cosmetic products.

Considering the SCCS opinions on Benzophenone-3 and Octocrylene, the Commission concluded that there is a potential risk to human health arising from the use of these ingredients as UV filters in the concentrations currently allowed and that their use should be restricted to the maximum concentration proposed by the SCCS.

Entries 4 and 10 of Annex VI to Cosmetics Regulation were replaced by the following:

Cosmetic products containing Octocrylene or Benzophenone-3 and complying with the restrictions set out in the European Cosmetics Regulation as applicable on 27 July 2022 may be placed on the market until 28 January 2023 and be made available on the market until 28 July 2023.

If you wish to get more information about this or other subjects, feel free to contact us at info@criticalcatalyst.com.

References:

1. Regulation (EC) No 1223/2009 of the European Parliament and of the Council of 30 November 2009 on cosmetic products.

2. Commission Regulation (EU) 2022/1176 amending Regulation (EC) No 1223/2009 of the European Parliament and of the Council as regards the use of certain UV filters in cosmetic products.

3. Scientific Committee on Consumer Safety (SCCS). Opinion on Octocrylene. SCCS/1627/21. 2021.

4. Scientific Committee on Consumer Safety (SCCS). Opinion on Benzophenone-3. SCCS/1625/20. 2021.

further
reading
cosmetic products

Citral under review: SCCS Preliminary Opinion

The SCCS was tasked by the European Commission to evaluate if the safety levels for Citral, determined through QRA2 based on skin sensitization induction, are sufficient to safeguard consumers. A preliminary opinion was released.

Read More »
Bruna Rolo July 25, 2024
cosmetic products

Are sunscreens with Benzophenone-4 safe?

Benzophenone-4 is commonly known as a UV-filter in cosmetic products. Learn what the final opinion of SCCS states about Benzophenone’s safety profile as a UV-filter in cosmetic products.

Read More »
Bruna Rolo July 19, 2024
cosmetic products

Is Aluminium in cosmetics safe for human health?

The Scientific Committee on Consumer Safety (SCCS) published its Final Opinion on the safety of Aluminium in cosmetic products. This follows a lengthy review process that began in 2013 when the SCCS was first mandated to evaluate the potential health risks of Aluminium (Al) and its compounds in cosmetics.

Read More »
Bruna Rolo July 1, 2024
cosmetic products

Silver in Cosmetics: SCCS preliminary opinion.

Ingredients: SILVER

The recent preliminary opinion from the Scientific Committee on Consumer Safety (SCCS) regarding silver in cosmetics is crucial for consumers and manufacturers. This article breaks down the key points, making it easier to understand the implications and stay informed.

Read More »
Bruna Rolo June 24, 2024
news & updates

EU Ecolabel adoption and recognition are on the rise

The Ecolabel certification is a comprehensive program focused on fostering sustainable practices. It evaluates products based on life cycle assessments, where every phase of said life cycle must abide by strict standards to attain the Ecolabel certification. The overarching objective of this certification is minimizing environmental harm from production or consumption activities.

Read More »
Bruna Rolo June 18, 2024
cosmetic products

UK proposes ban of wet wipes containing plastic 

The UK has proposed, on April 24, 2024, a regulation titled The Environmental Protection (Wet Wipes Containing Plastic) (England) Regulations 2024, to the World Trade Organization (WTO). The regulation aims to eliminate the supply and sale of plastic-containing wet wipes, including cosmetic ones. The public can offer comments on the draft until June 23, 2024, with adoption expected in September of the same year.

Read More »
Bruna Rolo June 14, 2024
news & updates

SCCS preliminary opinion on Citral sensitization endpoint

Ingredients: CITRAL

Date of publication: 27/03/2024

On March 27 2024, the Scientific Committee on Consumer Safety (SCCS) published the Preliminary Opinion on the safety of Citral in cosmetic products. The deadline for comments is set to June 2, 2024.

Read More »
Emanuel Valpaços July 25, 2023
medical devices

Safety Reporting in Clinical Investigations: a Gap Analysis of Guidance Documents 

Safety reporting in clinical investigations of medical devices shall be performed in line with Article 80(2) of the EU MDR. On May 2020, it was published the MDCG 2020-10/1, outlining the procedures for safety reporting in clinical investigations of medical devices under the EU MDR. However, on October 2022 the Medical Device Coordination Group (MDCG) published an updated version of the MDCG 2020-10/1, the MDCG 2020-10/1 Rev 1. This article highlights the updates included in the new revision, analysing the gaps between both documents.

Read More »
Guilherme Semedo February 24, 2023
medical devices

Roles and Responsibilities of an Authorised Representative under EU MDR and IVDR 

If a medical device manufacturer is not established in a Member State, the devices can only be placed on the Union market if the manufacturer designates an authorised representative. The authorised representative plays a pivotal role in ensuring the compliance of the devices with EU regulation, serving as point of contact. The obligations and responsibilities of authorised representative are outlined on Article 11 of both MDR and IVDR, but clarification of relevant requirements is described in MDCG 2022-16 of October 2022.

Read More »
Guilherme Semedo February 15, 2023
medical devices

Understanding the ISO Standards Lifecycle

ISO Standards cover a huge range of activities, representing the distilled wisdom of people with expertise in their subject matter and providing the regulators with a sound basis to develop better legislation. ISO Standards are diverse, addressing from the shoe size we wear to the quality of air we breathe. The medical device sector is no exception. ISO has many International Standards and guidance documents aimed at helping the sector ensure safe and effective medical devices while meeting the multitude of national, regional and international regulatory requirements. But how exactly is a Standard developed, reviewed and withdraw?

Read More »
Guilherme Semedo February 13, 2023

services

CONTACT US

  • info@criticalcatalyst.com
  • +351 91 200 43 51
    PT mobile network call
  • EUROPEAN UNION (HQ)
    679 Avenida da República
    4450-242 Matosinhos (PT)
  • UNITED KINGDOM
    49 Queen Victoria Street
    EC4N 4SA London (UK)